In this post, I link to and excerpt from Advanced airway management and respiratory care in decompensated pulmonary hypertension [PubMed Abscess] [Full-Text HTML] [Full-Text PDF]. Heart Fail Rev. 2022; 27(5): 1807–1817.
All that follows is from the above resource.
Abstract
Meticulous risk stratification is essential when considering intubation of a patient with decompensated pulmonary hypertension (dPH). It is paramount to understand both the pathophysiology of dPH (and associated right ventricular failure) and the complications related to a high-risk intubation before attempting the procedure. There are few recommendations in this area and the literature, guiding these recommendations, is limited to expert opinion and very few case reports/case series. This review will discuss the complex pathophysiology of dPH, the complications associated with intubation, the debates surrounding induction agents, and the available options for the intubation procedure, with specific emphasis on the emerging role for awake fiberoptic intubation. All patients should be evaluated for candidacy for veno-arterial extracorporeal membrane oxygen as a bridge to recovery, lung transplantation, or pulmonary endarterectomy prior to intubation. Only an experienced proceduralist who is both comfortable with high-risk intubations and the pathophysiology of dPH should perform these intubations.
Keywords: Intubation, Decompensated pulmonary hypertension, Respiratory failure, Cardiogenic shock
